Archive for July 1st, 2009
-
Jul 01, 2009
No CommentsThe cognitive change checklist (3CL): cross-validation of a measure of change in everyday cognition
In this study we examined further the reliability, validity, and efficacy of the 3CL in distinguishing among groups of normal individuals, those with cognitive complaints, amnestic and non-amnestic MCI cases, and early-stage demented individuals.Scale validation study.Alzheimer's Disease Research CenterOne hundred and twenty-five individuals who completed extensive evaluations as part of a longitudinal study of cognitive...
-
Jul 01, 2009
No CommentsRequest for Proposals Frontotemporal Dementia Drug Discovery Program
The Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Dementias (AFTD) seek to accelerate and support drug discovery for FTD and related dementias through this Request for Proposals (RFP). Research investigating the pathologic mechanisms of neurodegeneration in frontotemporal dementia (FTD) and related disorders has advanced recently, creating new potential targets for drug discovery. Examples of...
-
Jul 01, 2009
No CommentsEisai and Pfizer Decide not to Appeal NICE Decision and Call for an Expedited Review of Guidance for Alzheimer’s Disease
NICE Commit to Reviewing Existing Guidance 'As Soon As Possible' LONDON, July 1 (HSMN NewsFeed) -- On June 11, the National Institute for Health and Clinical Excellence (NICE) announced that, following consultation with stakeholders on the economic mo... Biopharmaceuticals, NeurologyEisai, Pfizer, Aricept, donepezil, Alzheimer's disease (Source: HSMN...
-
Jul 01, 2009
No CommentsPerspectives: 4 Alzheimer’s caregivers share their stories
Four Alzheimer's caregivers share their stories and tips in this roundtable discussion from ABC...
-
Jul 01, 2009
No CommentsHormone may affect neurological disease risk in women
Fluctuating hormone levels make women more vulnerable to ADHD, Alzheimer's, and schizophrenia at certain times of...
-
Jul 01, 2009
No CommentsPanel urges U.S. to compare Alzheimer’s, ADHD therapies
An Institute of Medicine (IOM) committee is urging the U.S. government to fund studies to compare treatment options for ADHD, Alzheimer's disease, and other...
-
Jul 01, 2009
No CommentsStatins may ward off Alzheimer’s
Patients who take a cholesterol-lowing statin may be protected against Alzheimer's disease, a new study has...
-
Jul 01, 2009
No CommentsFit Body, Fit Mind? Your Workout Makes You Smarter (preview)
As everybody knows, if you do not work out, your muscles get flaccid. What most people don’t realize, however, is that your brain also stays in better shape when you exercise. And not just challenging your noggin by, for example, learning a new language, doing difficult crosswords or taking on other intellectually stimulating tasks. As...
-
Jul 01, 2009
No CommentsEisai and Pfizer Decide not to Appeal NICE Decision and Call for an Expedited Review of Guidance for Alzheimer’s Disease
- NICE Commit to Reviewing Existing Guidance 'As Soon As Possible' LONDON, July 1/PRNewswire/ -- On June 11, the National Institute for Health and Clinical Excellence (NICE) announced that, following consultation with stakeholders on the economic... (Source: Drugs.com - Pharma...
-
Jul 01, 2009
No CommentsReview paper Genetic and environmental factors for hyperhomocysteinaemia and its clinical implications in Parkinson’s disease
Elevated homocysteine (Hcy) plasma levels are caused by genetic and environmental factors. Polymorphisms of Hcy metabolizing enzyme genes may result in its plasma increase. Experimental and clinical studies have shown the possible role of hyperhomocysteinaemia in pathogenesis of Parkinson’s disease (PD), Alzheimer’s disease and vascular disorders. The results of clinical studies in PD generally do...
